Related Experiment Video
Updated: Dec 19, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
Published on: February 6, 2021
Two Cases of Infant Botulism Presenting with Altered Mental Status
Marian August1, Mitchell Hamele1
1Tripler Army Medical Center, Honolulu, HI.
Insights
Infant botulism, a serious condition, can present atypically with altered mental status and fever. Early diagnosis and treatment are crucial for infants with unexplained weakness and constipation.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Background:
- Infant botulism, caused by *Clostridium botulinum* toxin, typically presents with descending weakness, facial palsies, and constipation.
- While *Clostridium botulinum* is widespread in the US, infant botulism is infrequently reported in Hawai'i.
Observation:
- This report details two infant botulism cases in Hawai'i with unusual initial symptoms: altered mental status (Patient A) and somnolence with fever post-immunization (Patient B).
- Patient A initially presented with inconsolability and progressed to loss of gag reflex and constipation, initially suspected as meningitis.
- Patient B exhibited somnolence and fever after immunizations, leading to consideration of metabolic disorders before botulism diagnosis.
Findings:
- Both patients were eventually diagnosed with infant botulism (toxin B for Patient A, toxin A for Patient B) despite atypical initial presentations.
- Altered mental status and fever are not typical early signs of infant botulism, highlighting diagnostic challenges.
Implications:
- Infant botulism should be considered in infants presenting with altered mental status, especially when accompanied by constipation and weakness, even if initial evaluations suggest other causes.
- Prompt consideration of infant botulism in infants with altered mental status and developing neuromuscular weakness is vital for timely diagnosis and treatment.
- Contacting the Infant Botulism Treatment and Prevention Program early is recommended for diagnostic and therapeutic assistance.
Abstract:
Infant botulism is a progressive process described as starting with descending weakness, facial palsies and constipation. Loss of bulbar reflexes and flaccid paralysis are common in infants less than 6 months old who have infant botulism. Clostridium botulinum, the bacteria that produce the toxin that causes this condition, are ubiquitous in the United States including Hawai'i, but infant botulism is rarely reported here. This report describes 2 cases of infant botulism with atypical initial presentations diagnosed on O'ahu, Hawai'i. Patient A is a 3-month-old male who presented with altered mental status, including inconsolability, who progressed to loss of gag reflex and constipation. Due to early concern for meningitis, Patient A was treated with antibiotics, however further evaluation led to eventual positive testing for botulinum B toxin. Patient B is a 2-month-old female who presented with somnolence and fever after immunizations and progressed to respiratory failure and apparent dehydration. Because she presented shortly after receiving immunizations, metabolic disorders were strongly considered as a potential cause of symptoms, but Patient B had normal metabolic evaluation and eventually tested positive for botulinum A toxin. Altered mental status and fever are unusual presentations for infant botulism. Infant botulism should be considered in infants with altered mental status when the course of illness includes the development of constipation and weakness, and evaluations are not suggestive of alternative causes, including infection, metabolic diseases, and spinal muscular atrophy. Early consideration and treatment of infant botulism should be considered for infants presenting with altered mental status who develop neuromuscular weakness. The Infant Botulism Treatment and Prevention Program (www.infantbotulism.org) should be contacted early for assistance with diagnosis and treatment.
More Related Videos
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015